- Type studie Fase 3 clinical trial, open label
- Betrokken instituten: Kempenhaeghe en Sein.
- Deelname: De trial is gesloten voor nieuwe patiënten.
- Titel studie: An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy for Seizures in Patients with Rare Seizure Disorders Such as Epileptic Encephalopathies Including Dravet Syndrome and Lennox-Gastaut Syndrome.
- Meer informatie: Link
